跳至主要内容
临床试验/NL-OMON24953
NL-OMON24953已完成不适用

The effect of protein hydrolysate supplementation to preserve muscle mass during immobilisation and enhance muscle regain during recovery

uritas0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 2) Aged 18-35 y
  • 3) BMI 18.5-30.0 kg/m2

排除标准

  • 1) (Family) history of thrombosis
  • 2) (Family) history of Factor V Leiden, or other known thrombophilia (such as; protein C, protein S, antithrombin deficiency)
  • 3) Lower limb, back or shoulder injuries (which may interfere with the use of crutches)
  • 4) Allergies to milk protein
  • 5) Lactose intolerance
  • 6) Participation in structured resistance exercise program
  • 7) All co-morbidities interacting with mobility and muscle metabolism of the lower limbs (e.g., arthritis, spasticity/rigidity, all neurological disorders and paralysis)
  • 8) Any medications known to (or may) affect protein metabolism (i.e., corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications)
  • 9) Diagnosed diabetes
  • 10) Diagnosed metabolic, cardiovascular or intestinal disorders
  • 11) A history of neuromuscular problems
  • 12) Use of anti-coagulants
  • 13) Use of protein and/or fish-oil supplements
  • 14) Participation in a 2H2O study in the previous 6 months.
  • 15) Smoking
  • 16) Any recent hospital admission/ major surgery

研究者

发起方
uritas

相似试验